Navigation Links
Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
Date:9/9/2008

BRIDGEWATER, N.J., Sept. 9 /PRNewswire-FirstCall/ -- Alpharma Inc. (NYSE: ALO), a global specialty pharmaceutical company, today announced results from its Phase III pivotal efficacy trial that showed ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) capsules provided significant pain relief in patients with moderate to severe pain due to osteoarthritis of the hip or knee compared to placebo. Findings also showed that ALO-01 capsules were safe and well-tolerated. This study was presented in a poster session at the 19th Annual Clinical Meeting of the American Academy of Pain Management in Nashville.

ALO-01 is an investigational pharmacologic abuse-deterrent, extended-release opioid that Alpharma is developing for the treatment of moderate to severe chronic pain. Utilizing Alpharma's proprietary technology, ALO-01 capsules combine an extended-release opioid, morphine sulfate, with a sequestered core of naltrexone, an opioid antagonist. When ALO-01 capsules are taken as directed, the naltrexone passes through the body without clinically meaningful release or accumulation.

According to the study findings, patients who were taking ALO-01 capsules reported significantly more effective pain relief, as measured by mean change in the weekly Brief Pain Inventory (BPI) Average Pain Intensity Score from baseline to the 12-week endpoint of the study, compared to patients who were taking placebo. Additionally, 72.5 percent of patients reported taking ALO-01 experienced pain relief of at least 30 percent from baseline, compared to 57.8 percent patients given placebo.

"These results are very exciting as we believe they demonstrate that ALO-01 has the potential to bring clear clinical ben
'/>"/>

SOURCE Alpharma Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 2015 Axxess , an industry leader ... software vendor accredited by the American Nursing Credentialing Center ... health agencies select the right revenue cycle management (RCM) ... their business. Research by American Health Information ... expect a decrease in productivity of 54.4 - 69 ...
(Date:6/29/2015)... Md. , June 29, 2015 The ... New Jersey Board of Professional ... a provider of courses to professional engineers for continuing ... accreditation further demonstrates the value and quality of PDA,s ... . "Our lecture courses and hands-on professional training at ...
(Date:6/29/2015)... SOUTH EASTON, Mass. , June 29, 2015 ... the "Company"), a leader in the development and ... sample preparation solutions to the worldwide life sciences ... of the Institute of Molecular Systems Biology, ETH ... the proteomic profiling and classification of prostate cancer ...
Breaking Medicine Technology:Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 3Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 4
... , CARLSBAD, Calif., Dec. 21 Isis Pharmaceuticals, Inc. (Nasdaq: ... $10 million payment from OncoGenex Pharmaceuticals, Inc. (Nasdaq: ... to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 is ... has completed a successful Phase 2 program in patients with ...
... , , , STOCKHOLM, December ... raising 380 MSEK (approximately 36,MEUR). This will secure Karolinska Development,s ... "The significant interest in this share issue shows ... us to pursue our long term,investment strategy. I am also ...
Cached Medicine Technology:Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva 2Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva 3Karolinska Development New Share Issue Completed - Raising 380 MSEK (36 MEUR) 2
(Date:6/30/2015)... ... 2015 , ... Curly Hair Solutions™ is honoured to attend Cosmoprof North America ... featuring products from all over the world. For the first time ever, Curly Hair ... hair styling products focused entirely on meeting the needs of all curl types ...
(Date:6/29/2015)... ... ... Sublime Beauty NATURALS® introduces its new USDA Certified Organic Sesame Oil this ... and even culinary uses, was especially designed for Oil Pulling. , To transform ... can accomplish this. Oil Pulling is an Ayurvedic practice that is easy and very ...
(Date:6/29/2015)... Kentucky (PRWEB) , ... June 30, 2015 , ... The ... Kentucky Orthopedic Rehab Team (KORT) as it becomes the Official Physical and Occupational Therapists ... the 2015 Rolex Kentucky Three-Day Event presented by Land Rover. , “The ...
(Date:6/29/2015)... ... June 30, 2015 , ... The ... Guidelines for Neuro Musculoskeletal Thermography and Sympathetic Skin Response Studies.* , The new ... first published in 2006, are intended to aid physicians and thermal technologists in ...
(Date:6/29/2015)... ... June 29, 2015 , ... Cosmetic Town Journal ... potential patients about a variety of plastic surgery and cosmetic procedures including: breast ... It has been the main focus of Cosmetic Town Journal to become the ...
Breaking Medicine News(10 mins):Health News:Curly Hair Solutions™ Showcases Entire Curl Keeper™ Collection at Cosmoprof Las Vegas July 12 - 14 2Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2Health News:KORT Physical Therapy Announces Partnership with The United States Equestrian Federation 2Health News:American Academy of Thermology Publishes Revised 2015 Guidelines for Neuro-Musculoskeletal Thermography and Sympathetic Skin Response Studies 2Health News:American Academy of Thermology Publishes Revised 2015 Guidelines for Neuro-Musculoskeletal Thermography and Sympathetic Skin Response Studies 3Health News:Board of Advisors Now Coming to Cosmetic Town 2
... Researchers at UT Southwestern Medical Center have found ... circadian rhythm, the 24-hour cycle that controls metabolism, sleep ... the brain called the suprachiasmatic nucleus (SCN) remains the ... it does so indirectly, according to a study published ...
... patient and treatment has become a major focus ... psychopharmacology of mental disorders. Genetic studies have suggested that ... less sensitive to stressful social environments but can ... preventative or therapeutic behavioral interventions? The current ...
... PROVIDENCE, RI New research from the Bradley Hasbro ... a child with obsessive compulsive disorder (OCD) will respond ... The findings, published in the October issue of the ... Adolescent Psychiatry, could help guide important clinical decisions ...
... Dotinga HealthDay Reporter , WEDNESDAY, Oct. 13 (HealthDay ... poor countries could help HIV-infected mothers and their infants more ... doctors lower the risk of transmission of mother-to-baby HIV infection ... to babies right after. About half of the babies avoid ...
... --- Northwestern University Feinberg School of Medicine is among ... initiative to invest $130 million over five years to ... of health workers. Through the Medical Education ... Health at Feinberg will participate in a consortium to ...
... popular lemon-lime soft drink could play an unexpected role ... The experiments produced evidence that patients will absorb more ... clinical trials, when taken with "flat" or degassed Sprite. ... a bi-monthly journal. Faraj Atassi and colleagues note ...
Cached Medicine News:Health News:Temperature rhythms keep body clocks in sync, UT Southwestern researchers find 2Health News:Perspectives on improving patient care: Genetics, personalized medicine, and behavioral intervention 2Health News:New research helps clinicians predict treatment outcomes for children with OCD 2Health News:Studies Tout Alternative HIV Regimens for Women, Babies 2Health News:Studies Tout Alternative HIV Regimens for Women, Babies 3Health News:Improving medical education in Africa 2
For regulating sample flow rate when using the QIAvac 24 Plus;...
For processing mini spin columns on QIAvac 24;...
DNA/RNA preparation in 8-multi channels...
... Filter Units,Filter units with hydrophobic PTFE ... membrane are ideal for the sterilizing ... sterile containers, and for sterilizing or ... mm Millex filter units are available ...
Medicine Products: